Mannkind (MNKD) Buildings (2024)
Mannkind (MNKD) reported Buildings of $43.5 million for Q4 2024, little changed on a QoQ basis from $43.5 million in Q3 2024.
Mannkind (MNKD) has 1 years of Buildings data on file, last reported at $43.5 million in Q4 2024.
- Quarterly Buildings changed N/A year-over-year to $43.5 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $43.5 million (changed N/A YoY) and the FY2024 annual result came in at $43.5 million, changed N/A from the prior year.
- Buildings held at $43.5 million in Q4 2024 per MNKD's latest filing, from $43.5 million in the prior quarter.
- Across five years, Buildings topped out at $43.5 million in Q3 2024 and bottomed at $43.4 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 43.50 Mn |
| Sep 30, 2024 | 43.50 Mn |
| Jun 30, 2024 | 43.40 Mn |